241 related articles for article (PubMed ID: 27460922)
1. Atypical ubiquitin ligase RNF31: the nuclear factor modulator in breast cancer progression.
Zhu J; Zhuang T; Yang H; Li X; Liu H; Wang H
BMC Cancer; 2016 Jul; 16():538. PubMed ID: 27460922
[TBL] [Abstract][Full Text] [Related]
2. The atypical ubiquitin ligase RNF31 stabilizes estrogen receptor α and modulates estrogen-stimulated breast cancer cell proliferation.
Zhu J; Zhao C; Kharman-Biz A; Zhuang T; Jonsson P; Liang N; Williams C; Lin CY; Qiao Y; Zendehdel K; Strömblad S; Treuter E; Dahlman-Wright K
Oncogene; 2014 Aug; 33(34):4340-51. PubMed ID: 24441041
[TBL] [Abstract][Full Text] [Related]
3. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
4. RNF31 mediated ubiquitination of A20 aggravates inflammation and hepatocyte apoptosis through the TLR4/MyD88/NF-κB signaling pathway.
Li S; Zheng X; Hu Y; You K; Wang J
Chem Biol Interact; 2021 Oct; 348():109623. PubMed ID: 34416243
[TBL] [Abstract][Full Text] [Related]
5. Atypical ubiquitin-binding protein SHARPIN promotes breast cancer progression.
Tian Z; Tang J; Yang Q; Li X; Zhu J; Wu G
Biomed Pharmacother; 2019 Nov; 119():109414. PubMed ID: 31518875
[TBL] [Abstract][Full Text] [Related]
6. Resonance assignments of the PUB domain of the RNF31 protein.
Song L; Zhong F; Tu X; Zhang J
Biomol NMR Assign; 2023 Dec; 17(2):189-192. PubMed ID: 37395936
[TBL] [Abstract][Full Text] [Related]
7. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase RNF181 stabilizes ERα and modulates breast cancer progression.
Zhu J; Li X; Su P; Xue M; Zang Y; Ding Y
Oncogene; 2020 Oct; 39(44):6776-6788. PubMed ID: 32973333
[TBL] [Abstract][Full Text] [Related]
9. [Lentivirus-mediated interference of E3 ubiquitin ligase RNF31 inhibits tumor-necrosis factor-α-induced activation of nuclear factor-κB pathway].
Chen J; Chen H; Zhan Y; Yang X; Yu M
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Dec; 34(12):1713-20. PubMed ID: 25537889
[TBL] [Abstract][Full Text] [Related]
10. RNF31 promotes proliferation and invasion of hepatocellular carcinoma via nuclear factor kappaB activation.
Hoshino K; Nakazawa S; Yokobori T; Hagiwara K; Ishii N; Tsukagoshi M; Igarashi T; Araki K; Harimoto N; Tokunaga F; Shirabe K
Sci Rep; 2024 Jan; 14(1):346. PubMed ID: 38172174
[TBL] [Abstract][Full Text] [Related]
11. The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development.
Chen Z; Ren D; Lv J; Xu Y; Xie M; He X; Shi W; Qian Q; Jing A; Ma X; Qin J; Ding Y; Geng T; Ma J; Liu W; Liu S; Ji J
Cell Signal; 2023 Jul; 107():110677. PubMed ID: 37028779
[TBL] [Abstract][Full Text] [Related]
12. A Molecular Mechanism To Switch the Aryl Hydrocarbon Receptor from a Transcription Factor to an E3 Ubiquitin Ligase.
Luecke-Johansson S; Gralla M; Rundqvist H; Ho JC; Johnson RS; Gradin K; Poellinger L
Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416634
[TBL] [Abstract][Full Text] [Related]
13. SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells.
Yang H; Yu N; Xu J; Ding X; Deng W; Wu G; Li X; Hou Y; Liu Z; Zhao Y; Xue M; Yu S; Wang B; Li X; Niu G; Wang H; Zhu J; Zhuang T
J Exp Clin Cancer Res; 2018 Feb; 37(1):24. PubMed ID: 29433542
[TBL] [Abstract][Full Text] [Related]
14. Regulation of P53 signaling in breast cancer by the E3 ubiquitin ligase RNF187.
Li X; Niu Z; Sun C; Zhuo S; Yang H; Yang X; Liu Y; Yan C; Li Z; Cao Q; Ji G; Ding Y; Zhuang T; Zhu J
Cell Death Dis; 2022 Feb; 13(2):149. PubMed ID: 35165289
[TBL] [Abstract][Full Text] [Related]
15. FOXK2 transcription factor suppresses ERα-positive breast cancer cell growth through down-regulating the stability of ERα via mechanism involving BRCA1/BARD1.
Liu Y; Ao X; Jia Z; Bai XY; Xu Z; Hu G; Jiang X; Chen M; Wu H
Sci Rep; 2015 Mar; 5():8796. PubMed ID: 25740706
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic ubiquitin E3 ligase activity of histone acetyltransferase Hbo1 for estrogen receptor α.
Iizuka M; Susa T; Tamamori-Adachi M; Okinaga H; Okazaki T
Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(7):498-510. PubMed ID: 28769019
[TBL] [Abstract][Full Text] [Related]
17. Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells.
Tecalco-Cruz AC; Ramírez-Jarquín JO; Cruz-Ramos E
Curr Drug Targets; 2019; 20(6):690-704. PubMed ID: 30324876
[TBL] [Abstract][Full Text] [Related]
18. TRIM11 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
Tang J; Luo Y; Tian Z; Liao X; Cui Q; Yang Q; Wu G
Neoplasia; 2020 Sep; 22(9):343-351. PubMed ID: 32599554
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitin ligase RNF2 stabilizes ERα and modulates breast cancer progression.
Yuan L; Li X; Yang H; Li H
Hum Cell; 2023 Jan; 36(1):353-365. PubMed ID: 36271315
[TBL] [Abstract][Full Text] [Related]
20. The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
Xia X; Huang C; Liao Y; Liu Y; He J; Shao Z; Hu T; Yu C; Jiang L; Liu J; Huang H
Cell Death Dis; 2021 Mar; 12(4):329. PubMed ID: 33771975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]